Cresset gets SOC 2 compliance
Cresset, an innovative provider of integrated in silico solutions for drug discovery, has completed its SOC 2Type 1 audit, achieving compliance with the leading industry standards for customer data security.
Pharmaceuticals, Biotechnology and Life Sciences
Cresset, an innovative provider of integrated in silico solutions for drug discovery, has completed its SOC 2Type 1 audit, achieving compliance with the leading industry standards for customer data security.
At today’s Annual General Meeting (AGM) of Idorsia Ltd (SIX: IDIA) held in Basel, Switzerland, shareholders voted in favor of…
Clasado Biosciences has signed a new exclusive distribution agreement with Shanghai Prochin, a division of health ingredient specialist, Alliance Nutrition Group, which will see galactooligosaccharide ingredient Bimuno GOS made available to health and nutrition formulators in China, marking another exciting step in the commercial growth of Bimuno GOS.
Asgard Therapeutics, a privately held biotech company pioneering in vivo direct cell reprogramming for cancer immunotherapy, today announced it selected…
ProKidney Corp., a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease, today announced the pricing of an…
Banook Group, global provider of technology and services for clinical trial operators, today announces two strategic acquisitions that enhance its…
Benchling, the R&D Cloud powering the biotech industry, today announced that global pharmaceutical company Sanofi is using Benchling across more than 1,500…
NMD Pharma A/S, a clinical-stage biotech company dedicated to developing novel and improved treatments for patients living with neuromuscular diseases,…
CordenPharma and Certest are partnering up to add ionizable lipids to CordenPharma’s complex LNP formulation services
Bristol Myers Squibb presented results from the Phase 3 CheckMate -9DW trial evaluating the dual immunotherapy combination of Opdivo® (nivolumab) plus Yervoy® (ipilimumab)…